Hepatitis

Chimeric antigen receptor-based immunotherapies show promise when directed at viral targets, but data are limited.

Late diagnosis of hepatitis B and C remains common and is driven by factors like older age, male sex, comorbidities, and limited healthcare engagement.

New evidence affirms hepatitis B birth-dose safety as the CDC makes it optional.

The CDC announced a significant change to the childhood immunization schedule that would reduce vaccine recommendations.

ACIP delayed the vote on the hepatitis B vaccine schedule amid ongoing controversy and misinformation surrounding vaccine safety and infant immunization.

Most US patients eligible for hepatitis B virus (HBV) treatment remain untreated, raising risks of liver disease and complications.

World Hepatitis Day 2025 and its theme, “Hepatitis: Let’s Break It Down,” emphasize the urgent need to remove barriers to prevention, testing, and treatment to reduce liver cancer and eliminate hepatitis by 2030.